Increasing Oral Medication Adherence for Metastatic Breast Cancer Patients
Trial Parameters
Brief Summary
Aim of this study is to optimize an adherence increasing intervention designed for metastatic Breast Cancer (BC) patients by applying a full factorial design in order to evaluate the optimal combination of three different intervention components.
Eligibility Criteria
Inclusion Criteria: * Patients with a diagnosis of metastatic BC * Patients with a prescription for any OAA (i.e. oral chemotherapy, endocrine therapy, and Cyclin-Dependent Kinase 4/6 Inhibitors) * Age \>18 years old * Patients with a personal smart phone with internet access * Willingness and ability to comply with scheduled visits and other trial procedures * Understanding and speaking Italian language * Written informed consent Exclusion Criteria: * Psychiatric disorders or conditions that might impair the ability to give informed consent * Comorbidity that may impact on compliance to study procedures